SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-058009
Filing Date
2024-03-04
Accepted
2024-03-04 17:23:49
Documents
14
Effectiveness Date
2024-03-04

Document Format Files

Seq Description Document Type Size
1 S-3ASR d753996ds3asr.htm S-3ASR 368768
2 EX-1.2B d753996dex12b.htm EX-1.2B 17229
3 EX-4.6 d753996dex46.htm EX-4.6 282079
4 EX-5.1 d753996dex51.htm EX-5.1 22278
5 EX-5.2 d753996dex52.htm EX-5.2 11422
6 EX-23.1 d753996dex231.htm EX-23.1 1623
7 EX-23.2 d753996dex232.htm EX-23.2 1529
8 EX-99.3 d753996dex993.htm EX-99.3 57896
9 EX-FILING FEES d753996dexfilingfees.htm EX-FILING FEES 54193
10 GRAPHIC g753996g0301081837862.jpg GRAPHIC 1680
11 GRAPHIC g753996g0301081851003.jpg GRAPHIC 1826
12 GRAPHIC g753996g0301125120926.jpg GRAPHIC 7057
13 GRAPHIC g753996g15w97.jpg GRAPHIC 3021
14 GRAPHIC g753996g85i97.jpg GRAPHIC 3924
  Complete submission text file 0001193125-24-058009.txt   842961
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277640 | Film No.: 24715996
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)